TPST - Tempest Therapeutics GAAP EPS of -$0.54 misses by $0.06
2023-08-11 04:27:51 ET
- Tempest Therapeutics press release ( NASDAQ: TPST ): Q2 GAAP EPS of -$0.54 misses by $0.06 .
- Tempest ended the second quarter with $17.6 million in cash and cash equivalents, compared to $31.2 million on December 31, 2022.
For further details see:
Tempest Therapeutics GAAP EPS of -$0.54 misses by $0.06